We are live on ! Find out more
AMU

ETRACS Alerian MLP Index ETN

Delisted

AMU was delisted on the 23rd of November, 2020.

43 hedge funds and large institutions have $226M invested in ETRACS Alerian MLP Index ETN in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 20 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

8% more capital invested

Capital invested by funds: $209M → $226M (+$16.5M)

2% more funds holding

Funds holding: 4243 (+1)

50% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 20

Holders
43
Holders Change
+1
Holders Change %
+2.38%
% of All Funds
0.93%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
10
Reduced
20
Closed
2
Calls
Puts
Net Calls
Net Calls Change

AMU Hedge Fund Activity: Q2 2019 in Review

43 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in ETRACS Alerian MLP Index ETN (AMU) for Q2 2019, worth a combined $226M — up 7.9% from $209M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new AMU positions and 2 closed out — a net gain of 1 holder — while 10 added to existing stakes and 20 trimmed.

The largest buyer was Wells Fargo, adding an estimated $23.2M. The largest seller was Aspiriant LLC, cutting an estimated $1.67M.

  • 43 institutional investors held ETRACS Alerian MLP Index ETN (AMU) as of Q2 2019, up from 42 in Q1 2019.
  • Funds reported $226M of ETRACS Alerian MLP Index ETN stock for Q2 2019, up 7.9% quarter-over-quarter.
  • 3 funds opened new ETRACS Alerian MLP Index ETN positions in Q2 2019 and 2 closed out, a net change of +1 holder.
  • The largest ETRACS Alerian MLP Index ETN buyer in Q2 2019 was Wells Fargo, an estimated $23.2M added.
  • The largest ETRACS Alerian MLP Index ETN seller in Q2 2019 was Aspiriant LLC, an estimated $1.67M sold.

Based on aggregated 13F filings for Q2 2019.